Sign Up to like & get
recommendations!
1
Published in 2017 at "Drugs"
DOI: 10.1007/s40265-017-0722-4
Abstract: Fluocinolone acetonide intravitreal implant 0.19 mg (ILUVIEN®) is a nonbiodegradable, injectable, corticosteroid implant that is approved in several countries, including the USA, for the treatment of diabetic macular edema (DME). ILUVIEN® releases fluocinolone acetonide at an…
read more here.
Keywords:
acetonide intravitreal;
implant iluvien;
fluocinolone acetonide;
intravitreal implant ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "European Journal of Ophthalmology"
DOI: 10.1177/11206721221151136
Abstract: Purpose To show an alternative surgical technique for the introduction of the intravitreal fluocinolone acetonide (FAc) implant (Iluvien®) into the vitreous cavity using a 23-gauge (G) trocar if it is retained during its implantation in…
read more here.
Keywords:
fac implant;
intravitreal;
fluocinolone acetonide;
acetonide fac ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s403259
Abstract: Abstract Fluocinolone acetonide (FAc) intravitreal implant (Iluvien®) is a corticosteroid implant indicated for the treatment of diabetic macular oedema (DMO) in patients who have previously received conventional treatment without good response, non–infectious posterior uveitis, and…
read more here.
Keywords:
intravitreal fluocinolone;
treatment;
implant iluvien;
fluocinolone acetonide ... See more keywords